×
Request Free Sample ×

Kindly complete the form below to receive a free sample of this Report

* Please use a valid business email

Leading companies partner with us for data-driven Insights

clients tt-cursor
Hero Background

South America Asthma Inhaler Device Market

ID: MRFR/HC/54555-HCR
200 Pages
MRFR Team
February 2026

South America Asthma Inhaler Device Market Research Report: By Type (Metered Dose Inhalers, Dry Powder Inhalers, Soft Mist Inhalers), By Mode of Operation (Manually Operated Inhaler Devices, Digitally-Operated Inhaler Devices), By End User (Hospitals & Clinics, Homecare) andBy Regional (Brazil, Mexico, Argentina, Rest of South America)- Forecast to 2035

Share:
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Purchase Options

South America Asthma Inhaler Device Market Summary

Our Impact
Enabled $4.3B Revenue Impact for Fortune 500 and Leading Multinationals
Partnering with 2000+ Global Organizations Each Year
30K+ Citations by Top-Tier Firms in the Industry

Industry Developments

Recent developments in the South America Asthma Inhaler Device Market have indicated an increasing focus on innovation and accessibility. Among significant players, Pfizer, AbbVie, and GlaxoSmithKline are ramping up efforts in Research and Development to enhance device efficacy and patient adherence. Current trends show a rise in the demand for digital inhalers, as they provide better management capabilities through connected technology. Meanwhile, Boehringer Ingelheim and Roche are actively promoting their latest inhalation therapies, addressing the growing prevalence of asthma in the region. In terms of mergers and acquisitions, Novartis acquired certain assets from a local firm in August 2023, aiming to boost its foothold in South America. As for market valuation, firms like Teva Pharmaceuticals and AstraZeneca have reported notable growth, contributing to a combined market increase of 15% in device sales over the past two years, specifically from April 2022 to April 2023. Regulatory frameworks are also evolving, with health authorities in Brazil and Argentina implementing policies to improve patient access to inhaler devices, underlining the increasing prioritization of asthma management in health agendas across South America.

Report Scope

Report Scope:
Report Attribute/Metric Source:Details
MARKET SIZE 2018112.0(USD Million)
MARKET SIZE 2024123.2(USD Million)
MARKET SIZE 2035309.0(USD Million)
COMPOUND ANNUAL GROWTH RATE (CAGR) 8.719% (2025 - 2035)
REPORT COVERAGERevenue Forecast, Competitive Landscape, Growth Factors, and Trends
BASE YEAR2024
MARKET FORECAST PERIOD2025 - 2035
HISTORICAL DATA2019 - 2024
MARKET FORECAST UNITSUSD Million
KEY COMPANIES PROFILEDPfizer, AbbVie, GlaxoSmithKline, Roche, Boehringer Ingelheim, Orion Corporation, Chiesi Farmaceutici, Mylan, Novartis, Sanofi, Elekta, AstraZeneca, Sun Pharmaceutical Industries, Teva Pharmaceuticals, Merck & Co
SEGMENTS COVEREDType, Mode of Operation, End User, Regional
KEY MARKET OPPORTUNITIESRising asthma prevalence, Increasing healthcare access, Advanced device technology adoption, Growing awareness of inhaler types, Expansion of telemedicine solutions
KEY MARKET DYNAMICSincreasing asthma prevalence, rising healthcare expenditure, technological advancements in devices, growing awareness and education, government support and regulations
COUNTRIES COVEREDBrazil, Mexico, Argentina, Rest of South America
Leave a Comment

FAQs

What is the expected market size of the South America Asthma Inhaler Device Market in 2024?

The South America Asthma Inhaler Device Market is expected to be valued at 123.2 million USD in 2024.

What is the forecasted market size for the South America Asthma Inhaler Device Market by 2035?

By 2035, the South America Asthma Inhaler Device Market is projected to reach 309.0 million USD.

What is the expected compound annual growth rate (CAGR) for the South America Asthma Inhaler Device Market from 2025 to 2035?

The market is expected to grow at a CAGR of 8.719% from 2025 to 2035.

Which type of asthma inhaler is expected to dominate the South America market in 2024?

Metered Dose Inhalers are expected to dominate with a valuation of 65.0 million USD in 2024.

What is the projected market value of Dry Powder Inhalers in 2035?

The Dry Powder Inhalers market is projected to be valued at 92.5 million USD by 2035.

What market share does Brazil hold in the South America Asthma Inhaler Device Market in 2024?

Brazil's market share is expected to be valued at 45.0 million USD in 2024.

What is the expected market size of Soft Mist Inhalers in 2024?

Soft Mist Inhalers are expected to have a market size of 20.2 million USD in 2024.

What is the projected market size for Argentina in the Asthma Inhaler Device Market by 2035?

By 2035, Argentina's market size is expected to reach 50.0 million USD.

Who are the major players in the South America Asthma Inhaler Device Market?

Key players in the market include Pfizer, AbbVie, GlaxoSmithKline, Roche, and Boehringer Ingelheim.

What is the expected market value for the Rest of South America region in 2035?

The Rest of South America is projected to have a market value of 78.0 million USD by 2035.

Download Free Sample

Kindly complete the form below to receive a free sample of this Report

Compare Licence

×
Features License Type
Single User Multiuser License Enterprise User
Price $4,950 $5,950 $7,250
Maximum User Access Limit 1 User Upto 10 Users Unrestricted Access Throughout the Organization
Free Customization
Direct Access to Analyst
Deliverable Format
Platform Access
Discount on Next Purchase 10% 15% 15%
Printable Versions